ZA9210004B - Stable salts of (+)-(1S,2R)-2-((N-(-2-hydroxylamino-2-oxoethyl)-N-methyl-amino)carbonyl)cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them - Google Patents
Stable salts of (+)-(1S,2R)-2-((N-(-2-hydroxylamino-2-oxoethyl)-N-methyl-amino)carbonyl)cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- ZA9210004B ZA9210004B ZA9210004A ZA9210004A ZA9210004B ZA 9210004 B ZA9210004 B ZA 9210004B ZA 9210004 A ZA9210004 A ZA 9210004A ZA 9210004 A ZA9210004 A ZA 9210004A ZA 9210004 B ZA9210004 B ZA 9210004B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydroxylamino
- oxoethyl
- cyclohexane
- carbonyl
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI913448A IT1252708B (it) | 1991-12-23 | 1991-12-23 | Sali stabili dell'acido (+)-(1r,2s)-2((n-(2-idrossilammino-2-ossoetil)-n-metilammino)carbonil)cicloesan-1-carbossilico,ad attivita' ace inibitrice, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9210004B true ZA9210004B (en) | 1993-12-13 |
Family
ID=11361409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9210004A ZA9210004B (en) | 1991-12-23 | 1992-12-23 | Stable salts of (+)-(1S,2R)-2-((N-(-2-hydroxylamino-2-oxoethyl)-N-methyl-amino)carbonyl)cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0575572A1 (ru) |
| JP (1) | JPH06506002A (ru) |
| CN (1) | CN1079474A (ru) |
| AU (1) | AU657591B2 (ru) |
| BG (1) | BG98050A (ru) |
| BR (1) | BR9205652A (ru) |
| CA (1) | CA2104372A1 (ru) |
| CZ (1) | CZ379692A3 (ru) |
| EE (1) | EE9400006A (ru) |
| FI (1) | FI933685A0 (ru) |
| HR (1) | HRP921454A2 (ru) |
| HU (1) | HUT69287A (ru) |
| IT (1) | IT1252708B (ru) |
| LV (1) | LV10426B (ru) |
| MA (1) | MA22749A1 (ru) |
| MX (1) | MX9207543A (ru) |
| NZ (1) | NZ245547A (ru) |
| PL (1) | PL169086B1 (ru) |
| PT (1) | PT101156A (ru) |
| RU (1) | RU2079489C1 (ru) |
| SI (1) | SI9200409A (ru) |
| SK (1) | SK379692A3 (ru) |
| TN (1) | TNSN92117A1 (ru) |
| WO (1) | WO1993013056A1 (ru) |
| YU (1) | YU110892A (ru) |
| ZA (1) | ZA9210004B (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1264860B1 (it) * | 1993-06-21 | 1996-10-17 | Guidotti & C Spa Labor | Derivati di acidi cis- e trans-2(((2-(isdrossiammino)-2-ossoetil)- alchilammino)carbonil)cicloesancarbossilici |
| US5639746A (en) * | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| FR2817241B1 (fr) | 2000-11-30 | 2003-03-07 | Cebal | Tube aluminium avec embout secable |
| AU2007302670A1 (en) * | 2006-09-28 | 2008-04-10 | Merck & Co., Inc. | Amine base salts of SAHA and polymorphs thereof |
| WO2021221984A1 (en) * | 2020-04-27 | 2021-11-04 | Carter-Hoffmann, Llc | Door movement system for cabinet |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1224627B (it) * | 1988-04-12 | 1990-10-04 | Guidotti & C Spa Labor | Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono. |
-
1991
- 1991-12-23 IT ITMI913448A patent/IT1252708B/it active IP Right Grant
-
1992
- 1992-12-12 JP JP5511398A patent/JPH06506002A/ja active Pending
- 1992-12-12 RU RU9293052414A patent/RU2079489C1/ru active
- 1992-12-12 HU HU9302389A patent/HUT69287A/hu unknown
- 1992-12-12 WO PCT/EP1992/002903 patent/WO1993013056A1/en not_active Application Discontinuation
- 1992-12-12 EP EP92924726A patent/EP0575572A1/en not_active Withdrawn
- 1992-12-12 BR BR9205652A patent/BR9205652A/pt not_active Application Discontinuation
- 1992-12-12 AU AU30871/92A patent/AU657591B2/en not_active Ceased
- 1992-12-12 CA CA002104372A patent/CA2104372A1/en not_active Abandoned
- 1992-12-21 CZ CS923796A patent/CZ379692A3/cs unknown
- 1992-12-21 NZ NZ245547A patent/NZ245547A/en unknown
- 1992-12-21 SK SK3796-92A patent/SK379692A3/sk unknown
- 1992-12-22 HR HR921454A patent/HRP921454A2/hr not_active Application Discontinuation
- 1992-12-22 SI SI9200409A patent/SI9200409A/sl unknown
- 1992-12-22 MA MA23040A patent/MA22749A1/fr unknown
- 1992-12-23 MX MX9207543A patent/MX9207543A/es unknown
- 1992-12-23 PL PL92297118A patent/PL169086B1/pl unknown
- 1992-12-23 LV LVP-92-358A patent/LV10426B/lv unknown
- 1992-12-23 YU YU110892A patent/YU110892A/sh unknown
- 1992-12-23 ZA ZA9210004A patent/ZA9210004B/xx unknown
- 1992-12-23 PT PT101156A patent/PT101156A/pt not_active Application Discontinuation
- 1992-12-23 TN TNTNSN92117A patent/TNSN92117A1/fr unknown
- 1992-12-23 CN CN92113839A patent/CN1079474A/zh active Pending
-
1993
- 1993-08-18 BG BG98050A patent/BG98050A/bg unknown
- 1993-08-20 FI FI933685A patent/FI933685A0/fi not_active Application Discontinuation
-
1994
- 1994-05-23 EE EE9400006A patent/EE9400006A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ379692A3 (en) | 1993-09-15 |
| CA2104372A1 (en) | 1993-06-24 |
| PT101156A (pt) | 1994-06-30 |
| IT1252708B (it) | 1995-06-26 |
| SK379692A3 (en) | 1995-04-12 |
| HRP921454A2 (en) | 1995-02-28 |
| LV10426B (en) | 1995-08-20 |
| BR9205652A (pt) | 1994-05-03 |
| HUT69287A (en) | 1995-09-28 |
| SI9200409A (en) | 1993-09-30 |
| YU110892A (sh) | 1996-01-08 |
| AU3087192A (en) | 1993-07-28 |
| EP0575572A1 (en) | 1993-12-29 |
| HU9302389D0 (en) | 1993-11-29 |
| PL297118A1 (en) | 1993-09-06 |
| JPH06506002A (ja) | 1994-07-07 |
| CN1079474A (zh) | 1993-12-15 |
| RU2079489C1 (ru) | 1997-05-20 |
| ITMI913448A0 (it) | 1991-12-23 |
| EE9400006A (et) | 1995-12-15 |
| MA22749A1 (fr) | 1993-07-01 |
| AU657591B2 (en) | 1995-03-16 |
| WO1993013056A1 (en) | 1993-07-08 |
| ITMI913448A1 (it) | 1993-06-23 |
| FI933685A (fi) | 1993-08-20 |
| FI933685A0 (fi) | 1993-08-20 |
| MX9207543A (es) | 1993-08-01 |
| LV10426A (lv) | 1995-02-20 |
| TNSN92117A1 (fr) | 1993-06-08 |
| NZ245547A (en) | 1995-12-21 |
| PL169086B1 (pl) | 1996-05-31 |
| BG98050A (bg) | 1994-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT60466A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
| HUT51254A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| DE3372845D1 (en) | Composition for solid pharmaceutical preparations of active vitamins d3 and process for preparation thereof | |
| HUT58060A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
| IL107221A0 (en) | Carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their preparation | |
| IL93845A0 (en) | Amino acid derivatives,their preparation and pharmaceutical compositions containing them | |
| HUT64065A (en) | Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| IL113625A0 (en) | Amino acid derivatives processes for their preparation and pharmaceutical compositions containing them and their use | |
| PT84064A (en) | Process for the preparation of novel amino acid derivatives and of pharmaceutical compositions containing the same | |
| IL106472A0 (en) | Hydroxamic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL79792A (en) | Amino acid derivatives,their preparation and pharmaceutical compositions containing them | |
| HUT50112A (en) | Process for producing phenoxyalkyl-carboxylic acid derivatives and pharmaceutical compositions containing them as active component | |
| HUT57204A (en) | Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them | |
| HUT41784A (en) | Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents | |
| ZA9210004B (en) | Stable salts of (+)-(1S,2R)-2-((N-(-2-hydroxylamino-2-oxoethyl)-N-methyl-amino)carbonyl)cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them | |
| IL93955A0 (en) | Amino acid derivatives,their preparation and pharmaceutical compositions containing them | |
| PT83565A (en) | Process for the preparation of acid aryl-heterocyclic-alcoxi-acetic derivatives and of pharmaceutical compositions containing same | |
| HUT43848A (en) | Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents | |
| HUT59917A (en) | Process for producing sulfonamide derivatives and pharmaceutical compositions containing them as active component | |
| IL80820A0 (en) | Imidazopyridazinealkenoic acid amides,processes and intermediate compounds for their preparation and pharmaceutical compositions containing them | |
| IL86168A0 (en) | Enkastins:new glycopeptides which act to inhibit enkephalinase,processes for their preparation and pharmaceutical compositions containing them | |
| HUT41757A (en) | Process for producing pharmaceutical compositions containing e-desmethyl-mevalonic acid derivatives and process for producing the active agents | |
| HU895952D0 (en) | Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them | |
| IL104144A0 (en) | Stable salts of(+)-(1s,2r)-2-((n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino)carbonyl)cyclohexane-1-carboxylic acid,process for their preparation and pharmaceutical compositions containing them | |
| IL93590A0 (en) | Acid addition salts of naphthalenmethanamino and pharmaceutical compositions containing them |